(WP)NCD/ICP/CAN/OOI
ENGLISH ONLY
REPORT REGIONAL SEMINAR ON CANCER EPIDEMIOLOGY AND CONTROL Convened by the REGIONAL OFFICE FOR THE WESTERN PACIFIC OF THE WORLD HEALTH ORGANIZATION Singapore, 7-18 October 1985
Not for Sale Printed and distributed by the Regional Office for the Western Pacific of the World Health Organization Manila, Philippines November 1985
V~/til~1 \,~."Pl'>J
"'-'~)_
lL':):~a. F(l:~~U~ii..:.:,~ ':
NOTE
The views expressed in this report are those of the consultant and
participants in the Regional Seminar on Cancer Epidemiology and Control and do not necessarily reflect the policies of the World Health Organization.
This report has been prepared by the World Health Organization Regional Office for the Western Pacific for governments of Member States in the Region and for those who participated in the Regional Seminar on Cancer Epidemiology and Control, held in Singapore, from 7 to 18 October 1985.
CONTENTS
1.
INTRODUCTION 1. 1 1.2 1.3
.............................................................................................
1
Ob jec t i ves and background •••••••••••.•••••••.••••••••• Organization and planning •••.••.•.••••.••••.•••••••••• Review of the progranzme ............................................................
1 1 2 2
2.
CANCER EPIDEMIOLOGY .............................................................................. ..
2.1 2.2 2.3
Descriptive epidemiology.............................. Cancer registries.. ............... ....... .................
2 5
Biology and etiology of cancer ••.•••••••••••••••••••••
5 7 7 7 7
3.
CANCER CONTROL .......................................................................................... 3.1 3 .. 2 Review of cancer control activities ...................................... Primary prevent ion ........................................................................ Early detection .•..••.•••.••.•••••...••••••.••••..••.• Organi~ation
3.3 3.4
3.5 3.6
Diagnosis and treatment ............................... of cancer control........................
9
9 12
Barriers to cancer control............................
3.7 4.
Evaluation of cancer control activities .••••••••••••••
13 13 13
EXERCISE IN PLANNING FOR CANCER. CONTROL •••••••••••••••••••• 4 .. 1
Group ass ignment ............................................................................
4.2
Individual country plan ••••. ••••••••• •••• •••••••••• •••
14
5.
EVALUATION OF THE SEMINAR .••••••••••••••••••••••••••••••••• 5.1 5.2
15 15 16
Assessment by participants •••••.••••.•••.••••••••••.•• Assessment by faculty.................................
6.
GUIDELINES FOR CANCER CONTROL IN THE REGION •••••••••••••••• 6.1 6.2 6.3 6.4 6.5 6.6 Primary prevention •.••.•.•••.•..•.•.••••••••••••••••.. Cancer control planning ••••••••.•.••.••••••••••.•••••• Cancer information systems .••••••.••••.•••••••••....•• Early detect ion .............................................................................. Management of cancer patients •••••••••••.••••••••••••• Periodic review of cancer control activities ••••••••••
16 17 17 17 18 18 18
ANNEX 1 - LIST OF PARTICIPANTS ••••••••••••••••••••••••••••. ANNEX 2 - QUESTIONNAIRE ON CANCER EPIDEMIOLOGY AND CONTROL.. ANNEX 3 - PROGRAMME
19 25 33
.......................................
ANNEX 4 - SEMINAR EVALUATION BY PARTICIPANTS •••••••••••••••
41
1.
INTRODUCTION
1.1
Objectives and background
Cancer is not only a leading cause of death in developed countries. but is also fast becoming a serious health problem in many developing countries of the Western Pacific Region. The First Regional Working Group on the Organization of Comprehensive Cancer Control Programmes was held in Manila in October 1975. The Second Working Group Meeting on the same theme. held in Manila in October 1979. recommended the formulation of a national plan as essential to the development of a comprehensive cancer control programme. The need arose to assess recent trends in cancer epidemiology. to review recent developments in cancer control, and to promote cancer control
in the Region. For these reasons. a Regional Seminar on Cancer Epidemiology and Control was held at the Regional English Language Centre in Singapore. from 7 to 18 October 1985. The seminar was attended by 15 participants from 12 countries/areas. 5 observers. 3 consultants. 4 temporary advisers. 1 local coordinator and 4 secretariat members (see Annex 1). The main objectives of the seminar were: (1) (2) (3) to exchange information on cancer epidemiology with special reference to the Western Pacific Region; to review recent developments in cancer prevention and control; to develop an understanding of the design and management of national cancer prevention and control programmes. based on an assessment of the problems and resources.
To obtain information on recent cancer incidence/mortality and cancer control activities in the Western Pacific, the participants were
requested to fill in a questionnaire on cancer epidemiology and control before the seminar (Annex 2). 1.2 Organization and planning
The seminar was organized and planned primarily by consultation among the faculty by mail and telephone. In addition. many of the faculty met in Singapore for four days before the seminar.
- 2 -
1.3
Review of the programme The programme had several major themes: (1)
the magnitude of the cancer problem as assessed by health and vital statistics and descriptive epidemiology; basic concepts 1n cancer biology and epidemiology for administration of cancer control activities; appropriate methods for primary prevention, early detection, diagnosis and treatment of cancers; planning, organization and administration of cancer control; evaluation of cancer control.
(2) (3) (4) (5)
The programme is given in detail in Annex 3. In interpreting the objectives and designing the course, the faculty felt it important to emphasize the practical aspects of canCer control, so that by the end of the seminar, participants should be able to assess the cancer control situation in their countries or regions and to prepare a draft plan for cancer control. Group and individual assignments were therefore included as major activities in the seminar.
2.
CANCER EPIDEMIOLOGY
2.1
Descriptive epidemiology A review of the cancer patterns in the Region was provided by: (1)
a summary of descriptive data on cancers of major importance in East Asia; a review of cancer incidence and mortality data collected in Oceania in recent years; country reports by the participants.
(2) (3)
2.1.1
Cancers of major significance in East Asia
Summaries of the descriptive epidemiology of the following cancers were discussed: nasopharynx, oesophagus, stomach, liver, cervix, lymphoma and leukaemia. Variations by geographical location, sex, age, migration status and time course were included.
I . 2.1.2
- 3 -
Cancer incidence and mortality in Oceania
Cancer is a growing public health problem in the island nations of the South Pacific. In several countries/areas (American Samoa, the Cook Islands, French Polynesia, Guam, Palau and Tonga), cancer is already responsible for over 15% of all recorded deaths. To judge from data on incidence, largely obtained from hospital pathology laboratories, cancer patterns appear to be similar among various populations of common ethnic origin, but to differ significantly between ethnic groups. The data on incidence are summarized in Table 1. The very notable difference in site-specific cancer rates among different ethnic groups living in the same country (e.g. Melanesians and Indians in Fiji; Melanesians and Europeans in New Caledonia; Maoris and Europeans in New Zealand) indicate the extent to which environmental determinants of cancer risk vary within population subgroups in theae countries, since genetic factors are unlikely to playa dominant role in cancer etiology. TABLE 1. LEADING CANCERS IN OCEANIA
Ethnic Group Melanesians
Countries for which data were available Fiji, New Caledonia, Papua New Guinea, Solomon Islands Cook Islands, Niue, New Zealand, Tahiti, American Samoa, Hawaii Federated States, Harshall Islands Palau, Guam Australia, New Zealand Hawaii
Males Liver, oral cavity stomach, lymphoma Lung, stomach, prostate, liver thyroid, lung Lung, liver, oral cavity, leukemia Lung, prostate, colon, rectum,
Females Breast, cervix,
liver, ovary, thyroid Breast, cervix, ovary, stom.ach,
Polynesians
Micronesians
Breast, cervix, lung, colon Breast, colon, lung, endometrium, cervix,
Caucasians
bladder, melanoma 2.1.3 Country reports
melanoma
Participants presented data on canCer incidence and mortality from their respective countries/areas. Variability in the quality of the data was noted, since the completeness of mortality reporting and the accuracy of diagnosis are not uniformly high throughout 'the Region. Furthermore, only a few participants were able to provide population-based incidence data from well-established cancer registries (Australia, China, Japan, New Zealand, Singapore). The proportion of deaths due to cancer, and the major cancers (based on either incidence or mortality data) in each country/area, as presented by the participants, are sU11llllsrized in Table 2.
TABLE 2.
CANCER
DEAT~S
AND INCIDENCE IN COUNTRIES/AREAS or Hajor H. 1 e Canc~r
T~E
THE WESTERN PACIFIC REGION
CAnc@r Dea ths
Deathe/Incidence Pemale _3_ _1_ _2_ -)-
~
1 22
!!!! 1983
Year 1982 1982 197)-75
1
_2_
Atutnlia (Queensland) Cline
2
lung lung
co lo-ree t um prostate eaoph8 aU8 lung lun& nae . . topoietic lytaph nodes liver skin lung lung stomach) cef"vilt ) prostate prostate oral liver _touch nasopharynx liver liv~r
pro.tate colo-rect~
breast breaU atocuch stomach stomach breast cervix breast breau IlOGoAch atOIDach
colo-rectulD eolo-rectw. cervix. lung lung cervi x breast lung skin lung uterus
lung _1.oOlla
3
20.6 27.4
1982 (20 cities) 1979
.tomaeh .tOfUch stomach liver connect.tia. lung lung stomach ttomach lung oro-pharynx) lung respiutory liver oral lung oral cavity .touch stomach lung lung lung
I iVf'r li.ver liver stoench liver .to. . ch
esophagus liver cervix haelNtopOletlc corpus uteri diae.tive luna uterus breaet
Cl'Iin. ( Shanghai) fiji Fre.,ch polyoeaia Japan Malaysia Hew Zealand
19:2-79 1972-79 1984 1980-84 1984 1984
2
12. I
1980-84
2
14
19£1<0
lip.onl cav. pharynx liver 1 ivel" leuke.i.) lung
23.8
1983
1983 1980 1983 1983 1983 1981 1983 1983 1980-81 1971-84 1982 19£1<0 19£1<0 1982
,.
4
10.3
1982
Hales. Fe:ulea breast breast 1 i. ver ct!rvllt breall breast $c"mach cervix lung breast cervix colon colon cervi. breast utl':['U5 I)ral C;lVlty liver stomach colo-reccutll colo-rectum breast lung me I anom4 leuk.emia liver
2
22.8
1983
colon colon leukemi~
Papua N~w Guinea Philippines Republ ic of Korea Singapore Viet Ham
12
1.6
1983
stomach leukemia lUII& lung
6
4.8
1980
leukemia cervix lung breast brea.t lung mouth
J
14.5
1982
lung ,tOUch 1 i Vt~r mouth
2
21.0
1984
liver 'tomach nasopharynx
3.8
1984 1976-80
\.
- 5 -
2.2
Cancer registries
The role of cancer registries in cancer control was discussed. Several problems in establishing a population-based registry in a developing country were cited, including deficiencies in census data,
incomplete demographic information on cancer patients, poorly developed health services, inadequate infrastructure for data collection, lack of manpower and limited financial resources. Both organizational and operational considerations in starting a registry were reviewed.
Although the value of cancer registries in assessing the cancer problem, in setting priorities for control programmes and in their evaluation was emphasized, possible alternative approaches, such as occasional surveys, were a2so di8cussed.
2.3 2.3.1
Biology and etiology of cancer Biology
A brief review of the carcinogenetic process was presented. A distinction was made between inherited cancers and cancers which are environmentally induced. The nature of cellular transformations in carcinogenesis and the role of oncogenes were discussed. The multistage theory, including the concepts of initiation and promotion, were developed, as these have been useful in epidemiological research. Finally, the nature of tumour growth and progression were presented as an introduction to the evaluation of cancer patient survival data. 2.3.2 Cancer patient survival Different measures of survival (including observed survival rates, median survival times and relative survival rates) were described, and
their strengths and limitations were noted. Common factors influencing survival rates (e.g. stage at diagnosis, age, sex, race, treatment) were discussed, and two important biases which can arise in the evaluation of screening programmes (lead-time bias and length-biased sampling) were explained. Illustrative data on variations in cancer patient survival by site, by stage and over time were presented and discussed. 2.3.3 Etiology
As an introduction to the discussion of the etiology of cancer, some basic epidemiological concepts and methods were reviewed for the benefit of the non-epidemiOlogists in the participant group. The distinction between observational and experimental research was made, and epidemiological approaches (including descriptive and analytic epidemiology, correlational analyses, case-control, cohort and intervention studies) were described. The strengths and weaknesses of these last three types of study were discussed. Finally, the concepts of relative and attributable risks were explained.
- 0 -
The etiology of cancer was presented in terms of categories of exposure as well as by site tor sel~cted cancers of importance in the
Region. (1) ( 2) (3)
The causes of cancer were categorized into five groups: hereditary, occupat iona 1; l i festyle,
(4) ( 5)
microbiologica 1, iatrogenic.
The discussion emvhasized lifestyle and micrubiological factors, since these seem tv be related to the major cancers affecting the Region. Lifestyle factors include smoking, betel quid Chewing, alcohulic beverages, diet and solar radiation. Salient features of the epidemiology of smoking an~ lung cancer, betel nut chewing and oral cancer, and alcuhol plus cigarette smoking and cancers of the oral cavity, larynx and oesophagus were presented. The current state of knowledge concerning the role of diet in the risk for cancer was reviewed. Data on nutrient components (fat, fibre, vitamin A, vitamin C) as well as specific roods (salted fish, pickled vegetables, smoked meats, fruits and vegetables) were presented and discussed. The fact that some constituents of foods may be protective against cancer was emphasized in the discussion. Finally, the role of solar radiation in the occurrence of skin cancer (melanoma as well as basal and squamous cell carcinomas) was discussed. In the category of microbiological factors, the role of viruses was discussed in greatest detail. Special attention was given to current evidence on the role of hepatitis B virus in the etiology of liver cancer. The extent of the evidence for the relationship of other viruses to cancer (Epstein-Barr virus and Burkitt's lymphoma or nasopharyngeal cancer, human papilloma virus and cervical cancer, herpes simplex type II virus and cervical cancer) was reviewed. Other microbiological agents, including the tungus Aspergillus flavus (producer of aflatoxin B) and the parasites Schistosoma haematobium, Clonorchis sinensis, and Opisthorchis felineus or
O. viverrini were discussed in terms of the evidence for their involvement in the etiology of selected cancers. As additional material for reviewing etiological factors, the partlcipants were provided with summaries of the risk factors associated
with each of the cancers of importance noted above in 2.1.2. The concept. of relative and attributable risk were reemphasi~ed in a concluding discussion on the contribution of each of the various etiological factors to the total cancer buruen. The fact that the proportion of all cancers attributable to individual causes varies among population groups (and even between the two ."xes) was demonstrated and emphasized.
- 7 -
3.
CANCER CONTROL
3.1
Review of cancer control activities The major techniques available for cancer control are primary
prevention, early detection and effective treatment, including pain control. Cancer control activities in the Western Pacific countries/areas are
summarized in Table 3. As to primary prevention, s~king control has been conducted in many countries to prevent lung cancer and other smoking-related diseases. Public education and legislation were major means of smoking control. In 7 out at 12 countries, there was national
legislation, regulation or voluntary agreement on the control of tobacco. In some countries, programmes tor the prevention of hepatocellular carcinoma by immunization using KBV vaccine, for the prevention of skin
cancer by public education on exposure to sunlight, and for the prevention of occupational cancer by reducing exposure to carcinogens in the work place have been conducted. As to early detection of cancer, in 9 out ot 12 countries cervical cancer screening using the Pap smear test has been conducted, although the percentage of women screened and the interval between screenings varied from country to country. Screening for other cancers has been conducted 1n some countries. In China, screening for oesophageal cancer, stomaCh cancer, colo-rectal cancer, liver cancer, lung cancer, breast cancer and nasopharyngeal cancer were conducted on a trial baSlS in high-rlsk areas for the corresponding cancers. Breast cancer screening has been conducted in 4 out of 12 countries. Stomach cancer screening has been conducted wideLy in Japan and on a trial basis in the Republic of Korea. As to diagnosis and treatment, cancer services were satisfactory in 6
out of 12 countries, but in some developing countries they were still limited. 3.2 Primary prevention
The control of tobacco smoking was the major primary prevention activity in the programme and it was given top priority in presentations by faculty and participants. Practical means of bringing about a reduction of smoking were fully discussed. Other primary prevention measures for sites other than the lungs, were given less emphasis. owing to there being less confidence in their ultimate effectiveness. The USe of a vaccine to prevent hepatitis B virus infection was fully discussed. in view of the importance of liver cancer in the We.tern Pacific Region. 3.3 ~arly
detection
The effectiveness of early detection of malignancy has not been established except for cancers of the uterine cervix and breast (mammography only). Self-examination of the breasts has not yet been shown to reduce mortality from breast cancer. The results of early detection of stomac~
cancer in Japan
wer~
reviewed.
In general, there appears to be no
- 8 -
TABLE 3.
CANCER CONTROL ACTIVITIES IN THE COUNTRIES/AREAS OF THE WESTERN PACIFIC REGION
..... 0" _ ~ III .s:: or. ... '" <= co u OJ <= <= co O'J :; -ro4 ..... .s:: <1l <1l
'" <=
~
.,
'"
<~
::0'6 6e + +
'" "
.c
"''" "
III
III
...., "'" ~
u " <= >.
"-
... c "-"-
(J-
Primary prevention 1. 2.
., .... ..... ., ... . ' " ..... Z ',., " '., ... .. " '" ., ..... co '" .... " ... c. ... :> <= '" '" " " "'" .... -, ;;! if: en z '" '" " "'" :> 0 N
-g
'., " <=
..... u
0. 0.
0 0. 0()
Z
0
0. .....
OJ
o.~
.D '" " OJ OJ 0
'" ..,
e
OJ ..... >
Legislation for tobacco control
N* V**
+
+
+
+
+
+
+
% of adult smokers - male
- female 3. Other programmes for primary prevention
39 30 +
60 5
75 3-5 +
55 45
66 14 + +
25 29
90 90 +
70 5
35 3 +
Early detection l.
Cervical cancer screening % of women screened in every X year Screening for other cancers 1) oral cancer
(+)
+
+
(+ )
+
+
(- )
+
+
+
+
36 I +
2.0 40 2.5 3-5 + +
10 +
25 I
20 2.4 0.5 1
2.
(-)
(+)
+
2) esophageal cancer 3) stomach cancer 4) colo-rectal cancer 5) liver cancer 6) lung cancer 7) breast cancer
+ + + + + +
+ + + +
+
(+) (+) (+) (+)
(+)
8) other cancers 3. Cancer services*** 1) cytology
NPC
2) pathology
3) 4) 5) 6)
imaging facilities cancer surgery radiotherapy chemotherapy 7) cancer pain relief 8) after carel rehabilitation
II II II il
" " " "
+ + + +
#
" " II
II II +
+ II + + + + + +
II II # +
II # + + +
/I
II g U 0 II /I /I
(/
II /I /I
+
II g
II (/
M
/I /I II + + +
+ + +
II II
II + + +
n
n # 1/
n
/I II /I II
H II # /I II
II # /I II
+
1/ II II + +
# +
II
II
II /I
*N = national legislation or regulation **v - voluntary agreement
***: # - more than 50% of the cancer patients + -
less than 50% of the cancer patients
= no service exist
- 9 -
firmly es 7 ablished scientific basis for the early warning signs of canCer ac many sites. The concepts of lead time and length bias in evaluating early detection were discussed. Where precursor lesions are parC of the natural history of cancer, their removal or treatment is a promising means of prevention. but this is a subject requiring research including intervention trials. ' 3.4 Diagnosis and treatment
In recent year., remarkable progress has been made in the treatment of cancer, mainly owing to early detection and multimodal treatment involving surgery, radiotherapy and chemotherapy. Chemotherapy is now effective in some types of cancer such as malignaat lymphoma, childhood leukaemia, testicular cancer, choriocarcinoma, and small-cell carcinoma of the lung. Early detection is still very important in the treatment of solid tumours such as stomach cancer, colo-rectal cancer, lung cancer, breast cancer and cervical cancer. To improve quality of life of cancer patients with pain, pain control was considered necessary. Pain control is important especially in countries/areas where facilities for cancer treatment are limited. 3.5 Organization of cancer control
To make best use of resources and ensure that cancer control programmes are as effective as possible, cooperation and coordination between governmental and nongovernmental organizations and between branches of those organizations are necessary. For this purpose, it is desirable to appoint a national cancer control coordinator or director who is responsible for overseeing the planning and implementation of the canCer control programme in the country. In Some developing countries, such a coordinator (or director) could be responsible for all noncommunicable diseases. The key elements in implementing cancer control programmes are legislation, public education and training, manpower, facilities and finance. The weight of each element differs depending on the teChniques of cancer control (Table 4). The establisn.ent of a cancer centre has several advantages. In 6 out of 12 countries, there is at least one cancer centre. Three of the remaining six countries had no cancer centre, but sll the services provided by a cancer centre were available, beiQg provided by other organizations (Table 5).
TABLE 4.
IMPLEMENTATION OF CANCER CONTROL PROGRAMMES ORGANIZATION AND ADMINISTRATION E I e men (C) Professional education/ training + t 8
(A)
(B) Public education
(D)
nee d e d
(E)
(F)
Cancer control activities 1.
Legislation (+)
Manpower +
Faci 1i t ie8/ .!.!!£PIi e s +
Budget +
Cancer registry Primary prevention amoking(chewing) control HBV control dietary control Early detection self exa.ination of brente cervical cancer acreening and other cancer screenings Diagnosis/treatment Pain control Relearch epidemiological c1 inica! basic
2.
+ (+)
+++ + +++
+ + +
+ + +
++
+ ++ +
3.
+++ +++
(+) +++
(+) +++ +++
(+) +++
.... 0
4. 5.
+++ +
+++ +
+++ +
+++ +
+
+ + ++
+ + +++
+/(++) ++ +++
not needed/not much needed + : some needed ++ : moderately needed +++ : much needed
'-
\.-
- II -
TABLE S.
ORGANIZATION OF CARCER CONTROL IN THE COUNTRIES/AREAS OF THB WESTERN PACIFIC REGION
" ......... .... III ..
"" .... ~ Qi
~
~
... '"
l'!
~8 < ..... .c u
. .... C
<9 ........ III ... +
.c Q/) .. c c ....... .. .c ""'
.c .. u c c c >-
>- 0
...
Organization of cancer control 1.
.... . ' " . .. ..... . " .... ... .. . ., . .... ..... - .. .. .,. .... .... " .. ..... :. ..., . " i! c: '" 1>.'" '"
... .. to
..... CI)
"'" "
Z
OJ
:.
0
n.
U
to
>-
Q.
N
.D ..
0.
0
%
~
to
" C Q. .....
Z
0.>.:r::>.: .. 0
or.
c
'-'
.....
QI
U)
l>
National cancer control progra_ National cancer society (l) public health education (2) cancer registry (3) primary prevention
+
+ +
(+)
+
... +
...
2.
+
+
+
+ +
+ +
+ + + +
... ... ... ...
+ + + +
+ +
+ +
+
+
...
(4) early detection (5) diagnosi8/treat~nt
(6) others 3. Cancer centre (1) public health education (2) cancer registry (3) early detection
...
... ...
+
...
+
+ +
...
... ...
+
...
+ +
... -*
...
...
...
... ... ...
... ... ...
...
... ...
...
-* ... + + + + + + + +
... ...
+
... ... ... ... ... ... + +
-*
(4) diagnosis/treat.ent (5) training
(6) clinical relearch (7) basic research (8) others 4. Barriers to cancer control (l) low priority (2) cancer is not a
+ + + + + + +
...
+
... ...
...
...
+
... ... ... ...
+
... ... ...
...
..
...
+
+ +
... ... +
.. ...
...
... ... ... ... ...
major problem (3) shortage of maapower (4) shortage of facilities (5) cultural/social factors
...
... ...
+ +
+ +
... +
(6) others
...
...
+
... ...
+ + +
... ...
...
... ...
...
*All the elements listed under cancer centre are available but are provided by other organizationl than a cancer centre.
- 12 -
3.6 3.6.1
Barriers to cancer control Lack of resources and skilled personnel
As shown in Table 3, many countries lack resources and personnel. For example, China lacks manpower and facilities. Less than one third of its provinces have special hospitals for cancer patients. Instruments for cancer diagnosis are increasingly more expensive, e.g. CAT scanners. In Papua New Guinea, cancer control started well in 1974 but many specialists have since left the country. A person should be designated as primarilY responsible for cancer. French Polynesia has no local treatment facilities for cancer and is obliged to send patients elsewhere, even to France. 3.6.2 Problems in pain control
Lack of adequate pain control is a problem in many developing countries and was a topic of considerable concern during the seminar. It constitutes one of the major barriers to cancer control. For example, in China most patients with cancer do not have adequate pain control. Owing to lack of facilities, strict control of narcotics and concern over addiction, following discharge, there is little access to powerful pain relievers such as morphine. In Papua New Guinea, pain control is inadequate since patients die at home generally far from medical care. 3.6.3 Social and cultural barriers
There are a variety of social and cultural barriers. Examples were given from many countries. In the Philippines, faith healers have been a problem. The people fear not only cancer, but also treatment by surgery and radiation. In Papua New Guinea, patients are diagnosed locally, but do not like being referred to the radiotherapy centre. They seek traditional healers and later come back to hospital with advanced disease. Cultural and social factors are barriers in Malaysia, despite the high priority given to cancer by the Government. Prevention is the best means of control, but depends on public and individual decisions. The latter is very hard to influence, e.g. decisions on smoking and betel quid chewing. There is a belief among Singapore Chinese, especially among the older age groups, that blood from orifices is due to tuberculosis. Late diagnosis for stomach and rectum cancer is often due to the primary care practitioners Who may interpret symptoms a8 peptic ulcer or haemorrhoidal bleeding. The attitude of many members of the medical profession is a barrier. For example, in New Zealand physicians are often unwilling to playa supportive role for cancer patients at home or to let other people give support. This applies both to general practitioners and specialists. An anecdote was told of an anaesthetiet in a provincial hospital who could not get permission from his surgical colleagues to admit patients to the hospital when he tried to set up a pain clinic.
I I \
I
)1
- 13 -
3.7
Evaluation of cancer control activities
The participants were introduced to the methodology of evaluation by a review of certain basic principles, including the purposes of evaluation, the need to incorporate an evaluation plan into the design of any control programme at the outset, and the requirements for snd types of comparisons that are appropriate. In order to provide the participants with a method they could use to plan and evaluate cancer control programs, a simple and rational approach to designing an evaluation scheme was presented. This approach Was based on a systematic outline that expressed the elements of the control programme in terms of discrete objectives (from long-range goals to immediate aims) in an orderly sequence. For each objective, suitable measures to assess it and pre-set criteria ror its successful achievement are required. Although the long-range objectives may not be measurable in the near term, they can be measured eventually; these are frequently referred to as "outcome measures". IDIIIediste Objectives, however, can be measured soon after implementation; these are frequently referred to as "process measures". It was emphasized that appropriate process measures are ones which can be reasonably expected to predict the long-range outcome. Failure to successfully achieve immediate objectives can therefore be a basis for interrupting or modifying a control eftort long before the final or long-term outcome is measured. Other aspects of a systematic approach to evaluation were discussed, including the importance of setting rational criteria for success rather than accepting just any level of achievement, the need to estimate the costs associated with each element of a cancer control programme, and the need to evaluate such a programme not only in terms of effactiveness (improvement in outcome) but also in efficiency (outcome in relationship to costs). These principles and the approach to evaluation were illustrated with an example based on a hypothetical cervical screening programme for a developing country. The participants then contributed cheir ideas and suggestions to a joint exercise in planning and evaluacing a primary prevention programme to reduce betel quid chewing in Papua New Guinea. This session provided the baai. for the evaluation schemes that the participants were to include in their group exercises and in their individual country plans.
4. EXERCISE IN PLANNING FOR CANCER CONTROL
4.1
Group assianment
The group assignment vas planned as a practical exercise in setting priorities for cancer control using data available in Singapore. Although Singapore has more data than many other countries in the Region, it was considered important to demonstrate how such data could be used in planning cancer control. This could lead to the establishment of simple cancer information systems in other countries.
- 14 -
The assignment was as follows: "Future Priorities for Cancer Control in Singapore You have been appointed by the Ministry of Health of Singapore to advise on the planning of cancer control up to the year 2000. Taking into account what is currently known about cancer incidence in Singapore, the cauaes of cancer, feasible means of prevention (both primary prevention and early detection), likely demographic trends such as ageing of the population, and current practical possibilities for effective treatment, outline your priorities for various aspects of cancer control in relation to
specific cancer sites. Give a timetable together with the rationale for your ranking. In addition, give more detailed plans for your two highest priorities, and state how you could evaluate the effectivenese of these two control activities." This assignment was introduced on the second day and the participants divided into three groups. This activity was one of the most successful activities in the seminar. All groups showed an orientation towards prevention with the primary prevention of lung cancer as the top priority. Two groups then gave priorities to other preventive measures and early detection, whereas one
group gave treatment as its second priority. Apart from lung cancer, most of the priorities for prevention were based on the absence of firm data on risk factors and illustrate the fact that administrators often make decisions without hard data. It is, therefore, not surprising that the priorities of the groups were different. One group (A) assigned priorities on the basis of potential years of life lost in 1983, whereas another (C) based its priorities on the projected number of cancers in Singapore up to the year 2000. 4.2 Individual country plan
The development of a country plan was a practical exercise in cancer control planning for each country. This individual assignment was considered useful for participants to apply what they learned through the seminar to a future cancer control plan. The assignment was aa follows: "A Cancer Control Programme for I
The following basic components of a cancer control programme are from the WHO document CAN/84.1~ (1)
Assessing the "burden" of cancer Documentation and review of current cancer control activities
(2)
lYour country, province, region or state.
- 15 -
(3) (4) (5) (6)
Determining potential new activities Setting priorities Implementation Evaluating and monitoring the control programme and cancer trends.
Using the above headings, outline a cancer control programme for up to the year 2000 (in around 4 pages typed in double-spacing). Take into account the priority that cancer should receive in relation to other health problems, botn now and in the future. Where information does not exist, outline what information would be needed, how it could be feasibly obtained and the proposed uses to which it could be put. Give a timetable for the various components of your proposed programme and how its cost-effectiveness might be assessed." This assignment was introduced on the second day and participants reported in the last two days following the reports of the group assignment. Cancer control plan. proposed by participants varied from country to country, depending on the magnitude of the cancer problem, the major cancers, the existing resources and geography in each country, and to some extent, the interest and position of participants. Common proposals were primary prevention of lung cancer by smoking control and cervical cancer control by Pap smear testing. Some participants gave priority to organization of cancer control, whereas others gave priority to the establishment or improvement of cancer registration. Although the development of individual country plans was only an exercise, it is expected that these country plans will be useful to future cancer control of their countries.
S.
EVA~UATION
OF THE SEMINAR
5.1
Assessment by participants
An evaluation session was conducted with participants by Dr Lee Hin Peng with other faculty absent. The questionnaire and numerical distribution of results are in Annex 4.A. Dr ~ee had an open discussion with participants and his report appears in Annex 4.8. Some comments by participants reflect their backgrounds in clinical and administrative aspects of cancer control and may not apply to future seminars with participants of di~ferent backgrounds.
- 10 -
The participants found the seminar to be very successful, especially the practical assignments in developing cancer control priorities and plans. They were positive that the seminar would help them develop cancer control programmes in their respective countries. 5.2 Assessment by faculty
All the faculty felt that the seminar aChieved its Objectives (see Section 1.1). In particular, the goal of making the seminar a very practical experience, with active involvement by the participants in useful cancer control exercises, appeared to have been met. The contributions of the representatives from might have been covered less comprehensively. Although the two-week period was not viewed as excessive by the participants, it did require 3 large commitment of time from busy faculty. Some saving in time might have been achieved if participants had been scheduled for some evening meetings to work on their group and individual assignments. ~HO
headquarters and the
IARC were especially helpful and provided expertise in areas that otherwise
In general, the faculty agreed with the assessment by the Greater interaction between faculty and participants could have been achieved if both groups had stayed at the same hotel. The need for discussion of the problems of canCer patient treatment and follow up is recognized. It seems that the formal presentation on cancer treatment was rather more technical than would have been desirable for this particular audience, and was based on the availability of more sophisticated and extensive resources for therapy than are available in many of the countries in the Region. partiCipants, as reviewed in section 5.1.
6.
GUIDELINES FOR CANCER CONTROL IN THE REGION
The seminar provided an opportunity to review can~er control activities in the Region. Considering responses to the questionnaire sent in advance to participants betore the seminar and discussion of country plans for future cancer control proposed during the seminar, the consultants propose the following guidelines for cancer control in the ~estern Pacific Region:
- 18 -
6.4
Early detection Early detection programmes are an important aspect of cancer control
where primary prevention activities cannot be implemented. (I) Because of the importance of cervical cancer as a major female cancer throughout the Region, and the established benefits of early detection through Pap smear screening, such programmes should be given high priority in cancer control planning, with due consideration for available resources and limitations. There is clearly a need for more Pap smear screening of high-risk groups in most of the countries in the Region. (2) Although methods for its secondary prevention are not established, oral cancer is of major importance in several popUlations of the Region. Thus, WHO should continue its efforts to establish the feasibility and benefits of early detection techniques for this cancer. 6.5 Management of cancer patients There are still many limitations in cancer treatment programmes in most of countries in the Region. Practical aspects of cancer treatment in
these countries need to be tackled. (1) The access of patients to adequate facilities for radiotherapy and the administration of chemotherapy is very limited in many countries and needs to be improved (e.g. by organizing access to standard chemotherapeutic drugs). (2) Pain control is a neglected aspect of cancer control in many countries. Efforts to improve pain control management in the countries of the Region should be assisted by WHO. (3) Improved quality of life is a major goal of cancer treatment but is very difficult to assess owing to differences in social, cultural and psychological factors. Adequate measures are needed. 6.6 Periodic review of cancer control activities
In addition to the above activities, it is important to review progress and developments in cancer control in the Region. This should be done by holding meetings with a practical problem-solving focus at five yearly intervals.
- 19 -
ANNEX 1
LIST OF PARTICIPANTS, OBSERVERS, CONSULTANTS, TEMPORARY ADVISERS, LOCAL COORDINATOR AND SECRETARIAT
1. PART! Cl PANTS
AUSTRALIA
Dr Ian Ring Director, Cancer Epidemiology and Prevention Unit Queensland Department of Health G.P. Box 48, Brisbane Queensland 4001 Dr Yu Shunzhang Dean, School of Public Health Shanghai Medical University 138-1 Hsueh Yuan Road Shanghai 200032 Dr Zhang You-hui Director, Cancer Institute Chinese Academy of Medical Sciences Beijing
CHINA
FIJI
Dr L.M. Seruvatu Consultant Government Pathologist Department of Pathology Colonial War Memorial Hospital Suva Dr Daniel Teterchen Technical Adviser to the Director of Public Health Department of Health Services Papeete
FRENCH POLYNESIA
JAPAN
Dr lch i ro Okubo Medica 1 Off icer National Hospital Division Health and Medical Service Bureau Ministry of Health and Welfare 1-2-2, Kasumigaseki Chiyoda-ku Tokyo 100
- 20 -
Ann~x
1
MALAYSIA
Dr Hj. Jalal bin Halil Khalil Medical Officer of Health Epidemiology Unit Ministry of Health Jalan Dungun Kuala Lumpur Dr Perdamen Singh Head and Senior Consultant in Radiotherapy and Oncology General Hospital Kuala Lumpur
1\ II
NEW ZEALAND
Dr Keith W. Ridings Assistant Director Division of Hospitals Health Department P.O. Box 5013 Wellington Dr Timothy Pyakalyia A/Coordinator, Noncommunicable Diseases Department of Health Headquarters P.O. Box 3991 Boroko Dr Tranquilino Elicano, Jr. Director National Cancer Control Center Ministry of Health Sta. Cruz, Manila Dr Jung Hyun Yang Staff Surgeon Department of General Surgery National Medical Center 6-Ka Ulchiro, Choong-Gu ~
I \
PAPUA NEW GUINEA
PHILIPPINES
REPUBLIC OF KOREA
SINGAPORE
Dr Ling Sing Lin Registrar Research and Evaluation Unit Ministry of Health Singapore
- 21 -
Annex I
SINGAPORE
Dr Low Cheng Hock Head Department of Surgery Tan Tack Seng Hospital Singapore Professor Luong Tan Truong Director
VIET NAM
Cancer Hospital Ho Chi Minh City
2.
OBSERVERS
Mr Mohan Chellappa Head Department of Surgery Changi Hospital Singapore Republic of Singapore Dr Fang Ngan Phoon Lecturer
Department of Social Medicine and Public Health National University of Singapore Outram Road Singapore Republic of Singapore Professor R. Nambiar
Head Department of Surgery B Singapore General Hospital Singapore Republic of Singapore Dr Bharathi Vaithinathan Training and Health Education Department Hinistry of Health Singapore Republic of Singapore
- 22 -
Annex 1
Dr Edward Yang Tuck Loong Radiotherapy Unit Singapore General Hospital Singapore Republic of Singapore
3.
CONSULTANTS
Dr S. Tominaga (Seminar Director) Vice Director Aichi Cancer Center Research Institute Chikusa-ku, Nagoya 464 Japan Dr L. Kolonel Professor University of Hawaii at Manoa Cancer Center of Hawaii 1236 Lauhala Street Honolulu, Hawaii 96813 United States of America Dr R. MacLennan Senior Principal Research Fellow Queensland Institute of Medical Research Bramston Terrace, Herston
Brisbane, Queensland Australia
II
II
l 4. TEMPORARY ADVISERS Dr Byung Soo Kim Director
Yonsei Cancer Center Yonsei University C.P.O. Box 8044 Seoul Republic of Korea
- 23 -
Annex 1
Dr Lee Hin Peng Professor Department of Social Medicine and Public Health National University of Singapore Outram Road Singapore Republic of Singapore Dr Oon Chong J in Professor University Department of Medicine (1) Singapore General Hospital Singapore
Republic of Singapore Dr K. Shanmugaratnam Professor and Head, Department of Pathology National University of Singapore Outram Road Singapore Republic of Singapore
5.
LOCAL COORDINATOR
Dr S.C. Emmanuel Deputy Director Research and Evaluation Section Ministry of Health Singapore Republic of Singapore
6. SECRETARIAT
WHO REGIONAL OFFICE FOR THE WESTERN PACIFIC
Dr Yusuke Terao (Operational Officer) Regional Adviser in Noncommunicable Diseases
WHO Regional Office for the Western Pacific P.O. Box 2932 Manila Philippines
- 24 -
Annex 1
Dr R.W.K. Gee NCO Epidemiologist (ICP/CVO/001) c/o The WHO Representative and Programme Coordinator P.O. Box 113 Suva Fiji WHO HEADQUARTERS Dr K. Stanley Scientist Cancer Unit, WHO Headquarters Geneva Switzerland
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
Dr D.H. Parkin Scientist Unit of Descriptive Epidemiology International Agency for Research on Cancer 150 cours Albert-Thomas 69372 Lyon, Cedex 08 France
- 25 -
ANNEX 2
QUESTIONNAIRE ON CANCER EPIDEMIOLOGY AND CONTROL Country/area: Name Title Mortality/Incidence 1.
What are the four most common causes of deaths in your country/area? Year: Proportion of all deaths certified by physicians: Rank 1
%
Causes of death
Number
% of all causes of deaths
2
3 4
If cancer death is not included in the four most common causes of deaths, please give the rank, number and % for cancer death below: Rank; _ _ _ _ __ 2. Number: %:
Is there a cancer registry in your country/area? ( ) Yes
(
) No
If yes, what is the type of cancer registry? ( ( ) Population-based cancer registry ) Hospital cancer registry
What areas are covered by cancer registry?
... /
- 26 -
Annex 2
1.
~lat are the 10 most common cance ry in your count ry/are a? Please give the numbe r, ~ of all sites of cance r and rate per 100 000 by site or canct! r. Giv~ first dt;!ath~ by sex; and if possi ble, incide nce by seX. Year: Area;
Rank
Sit~
or
cance r
Kate/l Oa lJiJil
2
3 4
1\ ,
6
7
8 9
I
10 All site. of cance r Femal es
.I 100.0 Site of cance r
Rank
No.
Kate/I OO 000
2 3 4
5 6
7 8
9
10 All sites of cance r 100.0
... /
- 27 -
Annex 2
Cancer incidence
Year: Area:
-------------------Rate/100 000
Males Rank 1 2
Site of cancer
No.
3 4
5 6 7 8 9
10
All sites of cancer Females Rank 1
100.0
Site of cancer
No.
Rate/lOO 000
2 3 4
5 6
7
8 9 1 'J
All sites of cancer
100.0
- 28 -
Annex 2
Organization of cancer control 4. Is there a national cancer control programme in the form of a coordinated national effort which includes the elements of prevention, early detection, therapy and aftercare in your country? No_ __
Yes
----
Comment s:
5.
Is there a national cancer society (non-governmental) or similar organization active in the field of cancer in your country? No , Yes ____ 1S
If yes, what ( ( ( ( ( ( ) ) ) ) )
its function?
public health education cancer registry primary prevention (smoking control, etc. ) early detection (cancer screening) diagnosis/treatment others:
)
If nOt are there other voluntary societies concerned with
cancer? If so, plea8e describe their activities and coverage of the popUlation.
6.
Is there any comprehensive cancer cent~r (cancer control center/cancer research center) in your country/area? No,_ __
Yes
... /
- 29 -
Annex 2
If yes, what ( ( ( ( ( ( ( ( ) ) ) )
1S
its function?
pub lie I,ealtll ~ducat ion cancer registry early detection (cancer
scre~ning)
) )
) )
diagnosis/treatment training clinical research "n cancer basic resea rch on canc~r others:
If no, how are the above functions carried out, if at all.
7.
What are the barriers to cancer control in your country/area? ( ( ( ( ( (
low priority 5iven to cancer control by the government/administration ) cancer 15 not a major health problem yet ) shortage of TDanpower ) shortage of he i li ties ) cultural or soc ia I factors ) others:
)
Primary prevention
8.
Is there national legislation, regulation or voluntary agreement on the control of tobacco? ( ) No
( (
) Yes, tnere 1S legislation or regulation ) Yes, there is voluntary agreement, but there is no legislation or regulation
9.
What i. the proportion of smokers/chewers in adults in your country/area? (If an exact proportion is not available, please give an approximate proportion in parentheses based on your best knowledge). Males ____,4 in year _ _ __
Females____% 1n year
... /
- 30 -
Annex 2
10.
Is there any other programme for primary prevention of cancer in your country/area? No_ _
Yes_ _
If yes. please describe it below:
Early detection (Secondary prevention)
11.
Is there an organized. cytology-based screening programme for cervical cancer in your country/area? No •
Yes
If yes. please give the proportion of target population regularly screened. (If an exact proportion is not available. please give an approximate proportion in parentheses based on your best knowledge).
______ 4 of women aged
years in every
-- year
If no. describe early detection activities.
12.
Is there any other organized screening programme(s) for cancers of
other sites in your country/area? No •
Yes
If yes. please indicate the site(s) of cancer and the proportion of target population regularly screened. (If an exact proportion is not available. please give an approximate proportion in parentheses based on your best knowledge) •
. . ./
- 31/32 -
Annex 2
( ( ( ( ( ( ( (
) ) ) ) ) ) ) )
Ora 1 cancer Esophageal cancer Stomach cancer Colo-rectal cancer Liver cancer Lung cancer Breas t cancer Other cancers:
% % % :t %
% % %
%
Cancer services
13.
Please indicate the level of existing cancer serVlce 1n the following areas available in your country/area: A service exists which serves:
No service exists 1. Cytology
less than 50% of the cancer patients
more than 50% of the cancer pat ients
2. Pathology 3. Imaging facilities and/or nuclear medicine 4. Cancer surgery 5. Radiotherapy 6. Chemotherapy (including immunotherapy) 7. Cancer pain relier (including narcotics) 8. Aftercare/rehabilitation _________
- 33 -
ANNEX 3
PROGRAM)1E Forma 1 sessions wi 11 be between 090() and 1630 dai ly Monday, 7 October 1985 0900 Official opening Dr S. Endo, Programm~ ~HO ~epresentative
and
Coordinator. Singapore
Dr S. Tominaga (Seminar Director) Vice Director Aichi Cancer Center Research Institute
Nagoya, Japan Dr Kwa Soon Bee
rhe Permanent Secreta ry(Heal th) I Director of Medical Services Ministry of Health, Singapore
0930 1030
Tea Orientation Dr Y. Terao (Operational Officer) Regional Adviser in Noncommunicable Diseases WHO/WPRO, Manila, Philippines Dr S.C. Emmanuel (Local Coordinat~r) Deputy Director Research and Evaluation Section )1inistry of Health, Singapore Dr S. Tominaga
1130
WHO cancer control strategy
Dr K. Stanley (Member, Secretariat) Scientist Cancer Unit, WHO Headquarters Geneva, Switzerland
- 34 -
Annex 3
1230 1!'00
Lunch Reports of the cancer incidencel mortality in each country/area by participants Descriptive cancer epidemiology in the Western Paciiic Region Dr S. Tominaga
1500
1.
East Asia
Dr D.M. Parkin (Member, Secretariat) Scientist Unit of Descriptive Epidemiology International Agency for Research on Cancer Lyon I Franc e
1545
2.
Oceania
L. Kolonel (Consultant) Professor University of Hawaii at Manoa Cancer Center of Hawaii Honolulu, Hawaii, U.S.A. Dr
Tuesday, 8 October 1985 Reports of cancer control activities in each country! area by participants Tea Reports (continued) Introduction to assignments
0900
Dr S. Tominaga
1030 1100 1130
Dr S. Tominaga Dr R. Maclennan (Consultant) Senior Principal Research Fellow Queensland Institute of Medical Research Brisbane, Australia
- 35 -
Annel( 3
1230
Lunch Epidemiologic approaches
1400
Dr L. Kolonel Dr O.M. Parkin Dr L. Kolonel
1445
Natural history and causes of cancer
1600
Discussion
Dr O.M. Parkin
Evening
Informal meeting of groups to discuss assignment
Wednesday, 9 October 1985 Primary prevention of cancer 0900
1.
Hepatitis H virus and liver cancer
Dr von Chong Jin (Temporary Adviser) Professor National University of Singapore Outram Road, Singapore Dr K. Stanley
0945 1030
2. Tea
Tobacco and cancer
Early detection of cancer 1100 1.
2. 3. 1200
Breast and cerViX Stomach Mouth
Dr O.M. Parkin Dr S. Tominaga Dr R. MacLennan Dr K. Stanley
Phases in developing cancer control programmes Lunch
1230
- 36 -
Annex 3
1400
Health educational activities against cancer undertaken in Singapore Groups meet to work on assignment
Dr Shirley Wan Deputy Director Training and Health Education Department Ministry of Health, Singapore All facu 1ty -
1500
tor consultation
Thursday, 10 October 1985 Diagnosis and treatment of cancer 0900
1.
Diagnosis and treatment of cancer
Dr Byung 500 Kim (Temporary Adviser) Director Yonsei Cancer Center Yonsei University 5eou l, Republic of Korea
II
1030
Tea Diagnosis and tr~atment of cancer (continued) Z. Pain control Or K. Stanley Dr R. Macl.ennan
1100 1145 1200 1230
,;
I ,
Models for setting priorities Lunch Groups meet - initially with faculty to review progress
1400
Faculty
Friday, 11 October 1985 0900
Organization and administration of cancer control
Dr S. Tominaga
- 37 -
Annex 3
0945
Barriers to cancer control activities
Dr R. MacLennan
1030 1100
Tea The cancer registry in cancer control
Dr K. Shanmugaratnam (Temporary Adviser) Professor and Head Department of Pathology National University of Singapore Outram Road. Singapore Dr Lee Hin Peng (Temporary Adviser) Professor Department of Social Medicine and Public Health National University of Singapore Outram Road. Singapore
1230 1400 1430
Lunch Groups meet Individuals me~t with faculty for 15 minutes to review country plans
Faculty
Saturday. 12 October 1985 0800
Departure for field visits to: Singapore General Hospital Gancer Registry (as per separate programme)
Dr S.C. Emmanuel
- 38 -
Annex 3
Monday
I
14 Dc tober 1985 Evaluation of canCdr control activities
0900
1.
Methodology
Dr L. Kolonel Dr 0.14. Parkin
1030 1100
Tea 2. 3. Group discussiun of published paper General discussion
Faculty Dr L. Kolonel
1200 1230 1400
Lunch Groups meet to work on assignment
Tuesday, 15 October 1985 0900 Review of topics selected by participants and faculty Tea Groups meet to finalize assignments and hand in for final typing Various faculty
/
1030 1100
1230 1400
Lunch Individuals meet with faculty to review progress on country plans Faculty
- 39 -
Annex 3
Wednesday. 16 October 1985 0900 Group A presentation
Dr R. MacLennan
of assignment
Discussion 1030 1100 Tea Group B presentation of assignment
Dr L. Kolonel
Discussion
1230 1400
Lunch Group C presentation of assignment Discussion
Dr s. Tominaga
1530
Work on indiviJual country plans
Thursday. 17 October 1985 0900 Review of topics or problems selected by participants and faculty WorK on individual country plans Tea Presentation of country plans - Plans 1 to 3 Various faculty Various faculty
0930
1030 1100
- 40 -
Annex 3
1230 1400
Lunch - Plans 4 to 8 Various faculty
Friday, 18 October 1985 0900 1030 1100 - Plans 9 to 11 Tea Evaluation of seminar
Various faculty
Dr Lee Hin Peng
by participants 1140
Future development of cancer control programmes in the Western Pacific Region General discussion and connents
Dr Y. Terao
1155
Dr L. Kolonel Dr R. MacLennan Dr S. Tominaga Dr S. c. Emmanue 1 Dr Y. Terao
1215
Conc luding remarks
- 41 -
ANNEX 4
SEMINAR EVALUATION BY PARTICIPANTS A. 1.
Questionnaire and numerical results Do you think the following objectives of this seminar were aChieved? Yes (1)
Pa rt ia lly 1
No
to exchange information of cancer epidemiology with special reference to the Western Pacific Region; to review recent developments in cancer prevention and control; to develop an understanding of the design and management of national cancer prevention and control programmes, based on an assessment of the problems and resources.
14
o o u
(2)
14
1
(3)
14
1
If "partially" or "no", why?
Not enough practical aspects.
2.
How would you rate the following major groups ot session? Very
Items
useful
Not usefu 1 4 3 2
5
1
( a) (b) (e)
Country reports Descriptive epidemiology EpidemiOlogical concepts and methods Natural history and causes of cancer Primary prevention
9
4 6
2 1
0 0
0
8 3 J 6
0 0 0
12 8 9
0 4
0 0
(d) ( e)
0
0
0
- 42 -
Annex 4
--(f)
Items
Very useful 5 4 3 2
Not useful I
Early detection Diagnosis and treatment Organization of cancer control
8 2
7 8 9 6 6
0
0 0 0 0 0 0 0
0 0 0 0 0 0 0
(gl (h)
5 1 1
5 8 9
(i l ( j) (k)
Evaluation of cancer cont ro I Group assignment Country plan Field visits (NR Kandouts i) lecture notes ii) books! document s iii) published articles s
0 0 2
10 1)
5 8
(l)
4
(m)
12
2
1 1
0 0 0 0
0 0 0 0
12 10
2
5 (,
0 0
( 0)
Overall grade (NR
=
1)
8
*NR
~
non-response
3. a) were there any specific topics which you felt should have been left out or reduced? Epidemiology - should decrease. Treatment and diagnosis - should be changed. b) were there any specific topics which you felt should have been included or increased? Chemical carclnogenesls - Pollution cOlltrol/occupation cancer
- Environmental and occupational issues Clinical aspects - Advances in treatment and cost-effectiveness Update on basic research - what is being done, new findings (in carcinogenesis, aetiology) studies on field application Organization of services - Strategies to get political and financial support Epidemiological methods - Intervention studies (cost-benefit and cost-effectiveness)
- 43 -
AnneK 4
4.
What do you think about the time given to the various activities during the seminar? Too much ( a)
Just right
Not enough 0 0 0
Lectures Discussions
0 L )
15 L4 L2 L2
( b) (0)
Group assignment Country plan Personal work (e. g. review handout s) Interaction with faculty* Interaction with participants*
(d) (e) (f)
L
2
1
10 13 11
4 2
0 0
(g)
4
5.
*Would have been better in a hotel with bar and pool What do you think about the length of the seminar?
o 11 4
too short just right too long
(suggest ion: ___ days)
(suggt!stion, _____ days)
2 suggested 7-10 days Z suggested 10 days
6.
a) Which part of the semlnar was most useful, and why? Overall development of cancer control programme (including assignments). Epidemiologic concepts and methods Discussions
b) which part of the seminar was least usetul, and why? Diagnosis and treatment (not up-to-date) Presentation of country plans (should have been given prior warning regarding this exercise)
-
~4
-
Annex 4
7.
What impact do you think that your attendance at this seminar will have on future cancer control efforts in your country? Posit ive No
effect
e f fec t 4
5 6
3
2
I
o
u
o
(NR
~
1)
Briefly explain your answer above. More optimism and enthusiasm
Better knowledge and understanding 8.
Do you think there should be other seminars like this 1n other parts of the world? _1_5_ Yes
o
No
Should be repeated in the Western Pacific Region 1n )-5 years (not earlier)for update and evaluation of programmes. 9. If this seminar were to be conducted again, how do you think it should be Changed?
II
More time for discussion. More clinicians and practitioners with experience in running cancer control programme.
J
More preparatory information on assignments to allow for better collection of necessary information.
10. Do you have any other comments about the seminar? Timetable should have been more flexible. 11. Do you have any comment. about your travel and hotel arrangements?
Hotel's airconditioner is turned off from 12 midnight to 6:30 a.m. Excursion travel did not allow for tlexibility in getting flights.
I
- 45 -
Annex 4
B. 1.
Report by Dr Lee Hin Peng General comments
The participants were generally very appreciative of the way the seminar was structured, organized and executed. They found it educational and stimulating, giving much credit to the faculty tor their contributions. The local organizers and secretariat were complimented for the smooth running of the seminar.. The venue was pleasant and coo\fenient, and the facilities were generally satisfactory. One participant suggested that, in future, an hotel wicn a bar and pool may be more conducive for better social interaction among participants and faculty. There was unanimous appreciation for the social programme, with thanks to the local coordinator and the Ministry of Health for their kind hospitality. 2. Objectives
Nearly all the participants agreed that the objectives were aChieved. Only one thought that the approach taken may have been a little too theoretical, indicating a lack of emphasis on the practical aspects of cancer control.
3.
Ratings of sessions Participants were asked to rate on a scale of five (from "1" not
useful to "5" very useful) all the major sessions. The distribution of grades are given in Annex 4. All the sessions commanded mainly grades of 5 or 4, indicating their usefulness. Relatively speaking, the following sessions were considered less useful: (a) (b) 4. natural history and causes of cancer diagnosis and treatment
Topics to be omitted or reduced
A few thought that the epidemiological component should be reduced, as contrasted to the relatively insufficient attention given to clinical aspects ot cancer control. The session on "Diagnosis and Treatment" was
considered too long, reducing the time available for discussion. Some of the points mentioned were likely to convey erroneous impressions, but there was no opportunity for discussion and clarification. 5. Topics to be included or increased
Related to the above comment, many participants felt that more experts on clinical aspects should have been invited to coqer the latest advances in cancer treatment, with discussions on practical problems faced in the Region's developing countries.
- 46 -
11
Annex 4
The following topics could have been included: a) chemical and radiation carcinogenesis, pollution control, occupational cancer and environmental issues, especially for the benefit of newly industrializing countries. b) update on basic research, reviewing the latest information on carcinogenesis, e.g. the role of oncogenes. There should have been discussions on how one can relate findings from basic research (e.g. molecular epidemiology) to field application. c) d) 6. more on organizational and management aspects of cancer control. more on methods in intervention studies.
Seminar activities
Most of the lectures (except one) were well executed - short presentations followed by discussion. Nevertheless, it was thought that more time should have been given to discussion. The timetable could have been made a little mOre flexible, allowing for changes by the day. The participants wanted more time for interaction with faculty and with each other. At least 3 participants felt that too much time was spent on the group assignment and insufficient time for country plans. 7. Length of seminar Four felt
Most thought that the two-week duration was just right. that it was too long and suggested a period of 7-10 days. 8. Useful and less useful parts
Most were agreed that the assignments in developing canCer control programmes were most useful. One thought that the presentation ot country reports was not very useful. It was suggested that participants be given ample warning about the assignments prior to leaving their countries. All were positive that they had obtained better knowledge and more enthu<iasm as well aa optimism in helping to develop a cancer control programme in their respective countries. 9. Future seminars
All were agreed that future seminars should be held in other parts of the world. It was thought helpful to consider holding another seminar in the Western Pacific Region in 3-> years' time (not earlier) to update scientific knowledge and evaluate progress of control programmes in member countries.
- 47/48 -
Annex 4
10.
For future seminars, the following were suggested: (a) Involve more clinicians and practitionerB with experience in
running cancer control programmes on the faculty. (b) 11. Provide more time for discussion and make the timetable more flexible.
Hotel and travel
There was a complaint that the Conference Hotel tended to switch off the air-conditioning from 12 midnight to 6:30 a.m. The excursion travel provided by WHO did not allow for flexibility in getting suitable and convenient flights.
I
I I I I